{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T06:05:00Z","timestamp":1770185100694,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"ANRF, India","award":["RJF\/2021\/000137"],"award-info":[{"award-number":["RJF\/2021\/000137"]}]},{"name":"ANRF, India","award":["ANRF\/ECRG\/2024\/000820\/LS"],"award-info":[{"award-number":["ANRF\/ECRG\/2024\/000820\/LS"]}]},{"name":"DHR, India","award":["SUG 2024-1136 reg"],"award-info":[{"award-number":["SUG 2024-1136 reg"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00109-026-02648-y","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:49:13Z","timestamp":1770133753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liver specific-inhibition of LPCAT3 ameliorates metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3188-6700","authenticated-orcid":false,"given":"Vijay","family":"Kondreddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramchandra Reddy","family":"Jala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhansi","family":"Magisetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"2648_CR1","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1053\/j.gastro.2006.02.040","volume":"130","author":"IJ Goldberg","year":"2006","unstructured":"Goldberg IJ, Ginsberg HN (2006) Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. Gastroenterology 130:1343\u20131346","journal-title":"Gastroenterology"},{"key":"2648_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104543","author":"Z Li","year":"2023","unstructured":"Li Z et al (2023) Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease. eBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104543","journal-title":"eBioMedicine"},{"key":"2648_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","volume":"70","author":"X Zhang","year":"2021","unstructured":"Zhang X et al (2021) Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut 70:761\u2013774","journal-title":"Gut"},{"key":"2648_CR4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24:908\u2013922","journal-title":"Nat Med"},{"key":"2648_CR5","doi-asserted-by":"publisher","first-page":"d3897","DOI":"10.1136\/bmj.d3897","volume":"343","author":"QM Anstee","year":"2011","unstructured":"Anstee QM, McPherson S, Day CP (2011) How big a problem is non-alcoholic fatty liver disease? BMJ 343:d3897","journal-title":"BMJ"},{"key":"2648_CR6","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G (2015) NAFLD: a multisystem disease. J Hepatol 62:S47\u2013S64","journal-title":"J Hepatol"},{"key":"2648_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee QM, Targher G, Day CP (2013) Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10:330\u2013344","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2648_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N et al (2018) The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67:328\u2013357","journal-title":"Hepatology"},{"key":"2648_CR9","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC et al (2020) Nonalcoholic steatohepatitis: a review. JAMA 323:1175\u20131183","journal-title":"JAMA"},{"key":"2648_CR10","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1073\/pnas.0712245105","volume":"105","author":"D Hishikawa","year":"2008","unstructured":"Hishikawa D et al (2008) Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversity. Proceed Nat Acad Sci 105:2830\u20132835","journal-title":"Proceed Nat Acad Sci"},{"key":"2648_CR11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0092-8674(89)90105-0","volume":"58","author":"T Nilsson","year":"1989","unstructured":"Nilsson T, Jackson M, Peterson PA (1989) Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell 58:707\u2013718","journal-title":"Cell"},{"key":"2648_CR12","doi-asserted-by":"publisher","first-page":"8258","DOI":"10.1074\/jbc.M710422200","volume":"283","author":"Y Zhao","year":"2008","unstructured":"Zhao Y et al (2008) Identification and characterization of a major liver lysophosphatidylcholine acyltransferase. J Biol Chem 283:8258\u20138265","journal-title":"J Biol Chem"},{"key":"2648_CR13","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","volume":"38","author":"Y Yan","year":"2013","unstructured":"Yan Y et al (2013) Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 38:1154\u20131163","journal-title":"Immunity"},{"key":"2648_CR14","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1194\/jlr.M800398-JLR200","volume":"50","author":"S Jain","year":"2009","unstructured":"Jain S et al (2009) Characterization of human lysophospholipid acyltransferase 3. J Lipid Res 50:1563\u20131570","journal-title":"J Lipid Res"},{"key":"2648_CR15","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06557","author":"X Rong","year":"2015","unstructured":"Rong X et al (2015) Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion. Elife. https:\/\/doi.org\/10.7554\/eLife.06557","journal-title":"Elife"},{"key":"2648_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27244-1","volume":"12","author":"Q Zhang","year":"2021","unstructured":"Zhang Q et al (2021) The structural basis for the phospholipid remodeling by lysophosphatidylcholine acyltransferase 3. Nat Commun 12:6869","journal-title":"Nat Commun"},{"key":"2648_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.gene.2010.09.002","volume":"470","author":"O Demeure","year":"2011","unstructured":"Demeure O et al (2011) Regulation of LPCAT3 by LXR. Gene 470:7\u201311","journal-title":"Gene"},{"key":"2648_CR18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cmet.2013.10.002","volume":"18","author":"X Rong","year":"2013","unstructured":"Rong X et al (2013) LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition. Cell Metab 18:685\u2013697","journal-title":"Cell Metab"},{"key":"2648_CR19","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/jgh.14461","volume":"34","author":"K Kakisaka","year":"2019","unstructured":"Kakisaka K et al (2019) Caspase-independent hepatocyte death: A result of the decrease of lysophosphatidylcholine acyltransferase 3 in non-alcoholic steatohepatitis. J Gastroenterol Hepatol 34:1256\u20131262","journal-title":"J Gastroenterol Hepatol"},{"key":"2648_CR20","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1172\/JCI93616","volume":"127","author":"X Rong","year":"2017","unstructured":"Rong X et al (2017) ER phospholipid composition modulates lipogenesis during feeding and in obesity. J Clin Invest 127:3640\u20133651","journal-title":"J Clin Invest"},{"key":"2648_CR21","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/labinvest.2012.128","volume":"92","author":"J Henkel","year":"2012","unstructured":"Henkel J et al (2012) Stimulation of fat accumulation in hepatocytes by PGE2-dependent repression of hepatic lipolysis, \u03b2-oxidation and VLDL-synthesis. Lab Investig 92:1597\u20131606","journal-title":"Lab Investig"},{"key":"2648_CR22","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.bbalip.2014.07.008","volume":"1851","author":"K Kawahara","year":"2015","unstructured":"Kawahara K, Hohjoh H, Inazumi T, Tsuchiya S, Sugimoto Y (2015) Prostaglandin E2-induced inflammation: relevance of prostaglandin E receptors. Biochim Biophys Acta 1851:414\u2013421","journal-title":"Biochim Biophys Acta"},{"key":"2648_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.it.2023.01.004","volume":"44","author":"JB Burkett","year":"2023","unstructured":"Burkett JB, Doran AC, Gannon M (2023) Harnessing prostaglandin E2 signaling to ameliorate autoimmunity. Trends Immunol 44:162\u2013171","journal-title":"Trends Immunol"},{"key":"2648_CR24","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2024.5356","author":"J Wang","year":"2024","unstructured":"Wang J et al (2024) Research progress, challenges and perspectives of phospholipids metabolism in the LXR\u2011LPCAT3 signaling pathway and its relation to NAFLD (Review). Int J Mol Med. https:\/\/doi.org\/10.3892\/ijmm.2024.5356","journal-title":"Int J Mol Med"},{"key":"2648_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.59566\/IJBS.2017.13048","volume":"13","author":"H Dana","year":"2017","unstructured":"Dana H et al (2017) Molecular mechanisms and biological functions of siRNA. Int J Biomed Sci 13:48\u201357","journal-title":"Int J Biomed Sci"},{"key":"2648_CR26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1208\/s12248-010-9210-4","volume":"12","author":"J Wang","year":"2010","unstructured":"Wang J, Lu Z, Wientjes MG, Au JL (2010) Delivery of siRNA therapeutics: barriers and carriers. AAPS J 12:492\u2013503","journal-title":"AAPS J"},{"key":"2648_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2796.2009.02189.x","volume":"267","author":"A Schroeder","year":"2010","unstructured":"Schroeder A, Levins CG, Cortez C, Langer R, Anderson DG (2010) Lipid-based nanotherapeutics for siRNA delivery. J Intern Med 267:9\u201321","journal-title":"J Intern Med"},{"key":"2648_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0378-5173(03)00082-6","volume":"255","author":"S Gao","year":"2003","unstructured":"Gao S et al (2003) Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. Int J Pharm 255:57\u201368","journal-title":"Int J Pharm"},{"key":"2648_CR29","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.biomaterials.2006.11.010","volume":"28","author":"A Sato","year":"2007","unstructured":"Sato A, Takagi M, Shimamoto A, Kawakami S, Hashida M (2007) Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice. Biomaterials 28:1434\u20131442","journal-title":"Biomaterials"},{"key":"2648_CR30","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/S0021-9258(19)68175-5","volume":"257","author":"PH Weigel","year":"1982","unstructured":"Weigel PH, Oka JA (1982) Endocytosis and degradation mediated by the asialoglycoprotein receptor in isolated rat hepatocytes. J Biol Chem 257:1201\u20131207","journal-title":"J Biol Chem"},{"key":"2648_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jconrel.2013.03.020","volume":"168","author":"M Zhang","year":"2013","unstructured":"Zhang M et al (2013) Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma. J Control Release 168:251\u2013261. https:\/\/doi.org\/10.1016\/j.jconrel.2013.03.020","journal-title":"J Control Release"},{"key":"2648_CR32","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/jgh.12878","volume":"30","author":"W Jiang","year":"2015","unstructured":"Jiang W et al (2015) MiR-146b attenuates high-fat diet-induced non-alcoholic steatohepatitis in mice. J Gastroenterol Hepatol 30:933\u2013943","journal-title":"J Gastroenterol Hepatol"},{"key":"2648_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/21691401.2018.1453830","volume":"46","author":"S He","year":"2018","unstructured":"He S et al (2018) Targeted delivery of microRNA 146b mimic to hepatocytes by lactosylated PDMAEMA nanoparticles for the treatment of NAFLD. Artificial Cells, Nanomedicine, and Biotechnology 46:217\u2013228","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology"},{"key":"2648_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01547-4","volume":"22","author":"V Kondreddy","year":"2024","unstructured":"Kondreddy V, Banerjee R, Devi B, Muralidharan K, Piramanayagam S (2024) Inhibition of the MALT1-LPCAT3 axis protects cartilage degeneration and osteoarthritis. Cell Communication and Signaling 22:189","journal-title":"Cell Communication and Signaling"},{"key":"2648_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.137235","volume":"282","author":"B Gadiraju","year":"2024","unstructured":"Gadiraju B, Magisetty J, Kondreddy V (2024) Transcription factor ETV4 plays a critical role in the development of non-alcoholic fatty liver disease. Int J Biol Macromol 282:137235","journal-title":"Int J Biol Macromol"},{"key":"2648_CR36","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1182\/blood-2017-10-813527","volume":"131","author":"V Kondreddy","year":"2018","unstructured":"Kondreddy V et al (2018) Factor VIIa induces anti-inflammatory signaling via EPCR and PAR1. Blood 131:2379\u20132392","journal-title":"Blood"},{"key":"2648_CR37","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1182\/blood.2022016424","volume":"140","author":"V Kondreddy","year":"2022","unstructured":"Kondreddy V et al (2022) The Gab2-MALT1 axis regulates thromboinflammation and deep vein thrombosis. Blood 140:1549\u20131564","journal-title":"Blood"},{"key":"2648_CR38","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1161\/ATVBAHA.121.316153","volume":"41","author":"V Kondreddy","year":"2021","unstructured":"Kondreddy V, Magisetty J, Keshava S, Rao LVM, Pendurthi UR (2021) Gab2 (Grb2-Associated Binder2) plays a crucial role in inflammatory signaling and endothelial dysfunction. Arterioscler Thromb Vasc Biol 41:1987\u20132005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2648_CR39","doi-asserted-by":"publisher","unstructured":"Jhansi L Magisetty J, Gadiraju B, Kondreddy V (2023) Genomic analysis in the colon tissues of omega-3 fatty acid-treated rats identifies novel gene signatures implicated in ulcerative colitis. Int J Biol Macromol 128867. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128867","DOI":"10.1016\/j.ijbiomac.2023.128867"},{"key":"2648_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jnutbio.2015.10.005","volume":"28","author":"VK Kondreddy","year":"2016","unstructured":"Kondreddy VK, Anikisetty M, Naidu KA (2016) Medium-chain triglycerides and monounsaturated fatty acids potentiate the beneficial effects of fish oil on selected cardiovascular risk factors in rats. J Nutr Biochem 28:91\u2013102","journal-title":"J Nutr Biochem"},{"key":"2648_CR41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nature17662","volume":"533","author":"J Li","year":"2016","unstructured":"Li J et al (2016) An obligatory role for neurotensin in high-fat-diet-induced obesity. Nature 533:411\u2013415","journal-title":"Nature"},{"key":"2648_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1194\/jlr.M600353-JLR200","volume":"48","author":"F Basso","year":"2007","unstructured":"Basso F et al (2007) Hepatic ABCG5\/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited. J Lipid Res 48:114\u2013126","journal-title":"J Lipid Res"},{"key":"2648_CR43","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/hep.24066","volume":"53","author":"M Guan","year":"2011","unstructured":"Guan M, Qu L, Tan W, Chen L, Wong CW (2011) Hepatocyte nuclear factor-4 alpha regulates liver triglyceride metabolism in part through secreted phospholipase A\u2082 GXIIB. Hepatology 53:458\u2013466. https:\/\/doi.org\/10.1002\/hep.24066","journal-title":"Hepatology"},{"key":"2648_CR44","doi-asserted-by":"publisher","DOI":"10.1172\/jci140989","author":"AK Singh","year":"2021","unstructured":"Singh AK et al (2021) Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice. J Clin Invest. https:\/\/doi.org\/10.1172\/jci140989","journal-title":"J Clin Invest"},{"key":"2648_CR45","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","volume":"142","author":"DY Oh","year":"2010","unstructured":"Oh DY et al (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142:687\u2013698","journal-title":"Cell"},{"key":"2648_CR46","doi-asserted-by":"publisher","first-page":"8796","DOI":"10.1093\/nar\/gku531","volume":"42","author":"TP Prakash","year":"2014","unstructured":"Prakash TP et al (2014) Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice. Nucleic Acids Res 42:8796\u20138807","journal-title":"Nucleic Acids Res"},{"key":"2648_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1055\/s-0039-1685524","volume":"39","author":"RJ Schulze","year":"2019","unstructured":"Schulze RJ, McNiven MA (2019) Lipid droplet formation and lipophagy in fatty liver disease. Semin Liver Dis 39:283\u2013290. https:\/\/doi.org\/10.1055\/s-0039-1685524","journal-title":"Semin Liver Dis"},{"key":"2648_CR48","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P (2018) Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci 75:3313\u20133327","journal-title":"Cell Mol Life Sci"},{"key":"2648_CR49","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06328","author":"T Hashidate-Yoshida","year":"2015","unstructured":"Hashidate-Yoshida T et al (2015) Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport. Elife. https:\/\/doi.org\/10.7554\/eLife.06328","journal-title":"Elife"},{"key":"2648_CR50","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1074\/jbc.M605023200","volume":"282","author":"J-Y Cha","year":"2007","unstructured":"Cha J-Y, Repa JJ (2007) The liver X receptor (LXR) and hepatic lipogenesis: the carbohydrate-response element-binding protein is a target gene of LXR*. J Biol Chem 282:743\u2013751","journal-title":"J Biol Chem"},{"key":"2648_CR51","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301744R","volume":"38","author":"NF Inagaki","year":"2024","unstructured":"Inagaki NF, Nakanishi H, Ohto T, Shindou H, Shimizu T (2024) LPCAT3\/LPLAT12 deficiency in the liver ameliorates acetaminophen-induced acute liver injury. FASEB J 38:e23328","journal-title":"FASEB J"},{"key":"2648_CR52","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1038\/onc.2014.439","volume":"34","author":"CA Lewis","year":"2015","unstructured":"Lewis CA et al (2015) SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme. Oncogene 34:5128\u20135140","journal-title":"Oncogene"},{"key":"2648_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/2049-3002-1-3","volume":"1","author":"B Griffiths","year":"2013","unstructured":"Griffiths B et al (2013) Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth. Cancer Metab 1:3","journal-title":"Cancer Metab"},{"key":"2648_CR54","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.2174\/13816128113199990486","volume":"20","author":"D Guo","year":"2014","unstructured":"Guo D, Bell EH, Mischel P, Chakravarti A (2014) Targeting SREBP-1-driven lipid metabolism to treat cancer. Curr Pharm Des 20:2619\u20132626","journal-title":"Curr Pharm Des"},{"key":"2648_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04664-0","volume":"9","author":"A Talebi","year":"2018","unstructured":"Talebi A et al (2018) Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy. Nat Commun 9:2500","journal-title":"Nat Commun"},{"key":"2648_CR56","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev-physiol-020518-114444","volume":"81","author":"B Wang","year":"2019","unstructured":"Wang B, Tontonoz P (2019) Phospholipid remodeling in physiology and disease. Annu Rev Physiol 81:165\u2013188","journal-title":"Annu Rev Physiol"},{"key":"2648_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.128867","volume":"258","author":"J Magisetty","year":"2024","unstructured":"Magisetty J, Gadiraju B, Kondreddy V (2024) Genomic analysis in the colon tissues of omega-3 fatty acid-treated rats identifies novel gene signatures implicated in ulcerative colitis. Int J Biol Macromol 258:128867","journal-title":"Int J Biol Macromol"},{"key":"2648_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35001-1","volume":"13","author":"S Minato-Inokawa","year":"2023","unstructured":"Minato-Inokawa S et al (2023) Associations of alanine aminotransferase\/aspartate aminotransferase with insulin resistance and \u03b2-cell function in women. Sci Rep 13:7853","journal-title":"Sci Rep"},{"key":"2648_CR59","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06557","volume":"4","author":"X Rong","year":"2015","unstructured":"Rong X et al (2015) Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion. eLife 4:e06557. https:\/\/doi.org\/10.7554\/eLife.06557","journal-title":"eLife"},{"key":"2648_CR60","doi-asserted-by":"publisher","first-page":"20122","DOI":"10.1074\/jbc.M111.334664","volume":"287","author":"Z Li","year":"2012","unstructured":"Li Z et al (2012) Lysophosphatidylcholine acyltransferase 3 knockdown-mediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expression*. J Biol Chem 287:20122\u201320131","journal-title":"J Biol Chem"},{"key":"2648_CR61","doi-asserted-by":"publisher","first-page":"148140","DOI":"10.1016\/j.ijbiomac.2025.148140","volume":"330","author":"V Kondreddy","year":"2025","unstructured":"Kondreddy V et al (2025) LPCAT3-ABCA1 axis regulates the dose-sparing effects of steroid drugs in osteoarthritis in mice. Int J Biol Macromol 330:148140","journal-title":"Int J Biol Macromol"},{"key":"2648_CR62","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00011-025-02132-2","volume":"74","author":"V Kondreddy","year":"2025","unstructured":"Kondreddy V et al (2025) LPCAT3-dependent remodeling of the phospholipids and lipid rafts is essential for vascular proinflammatory signaling and the development of atherosclerosis. Inflamm Res 74:163","journal-title":"Inflamm Res"},{"key":"2648_CR63","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.RA120000737","volume":"62","author":"T Bourgeois","year":"2021","unstructured":"Bourgeois T et al (2021) Deletion of lysophosphatidylcholine acyltransferase 3 in myeloid cells worsens hepatic steatosis after a high-fat diet. J Lipid Res 62:100013","journal-title":"J Lipid Res"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02648-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-026-02648-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02648-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:02:29Z","timestamp":1770138149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-026-02648-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2648"],"URL":"https:\/\/doi.org\/10.1007\/s00109-026-02648-y","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments were conducted following the established guidelines of the Institute Animal Ethics Committee approved by the CSIR\u2014Indian Institute of Chemical Technology, Hyderabad, India.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}